Feedback / Questions
Undisclosed SSTR2 radiotherapeutic - Ratio Therap, Novartis
https://www.prnewswire.com/news-releases/ratio-enters-license-and-collaboration-agreement-with-novartis-for-sstr2-targeting-radiotherapeutic-candidate-302307509.html
 
Nov 18, 2024
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious